|
Volumn 105, Issue 11, 2002, Pages 1348-1353
|
BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy
a a a a a a a a a a a a |
Author keywords
Adenosine antagonist; Congestive heart failure; Diuretics; Renal function
|
Indexed keywords
ADENOSINE A1 RECEPTOR ANTAGONIST;
BG 9179;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
FUROSEMIDE;
NAXIFYLLINE;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DIURESIS;
DIURETIC THERAPY;
DOUBLE BLIND PROCEDURE;
DRUG MECHANISM;
FEMALE;
GLOMERULUS FILTRATION RATE;
HEMODYNAMICS;
HUMAN;
KIDNEY FUNCTION;
MAJOR CLINICAL STUDY;
MALE;
NATRIURESIS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
URINE VOLUME;
AGED;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
BLOOD PRESSURE;
CREATININE;
CROSS-OVER STUDIES;
DIURESIS;
DIURETICS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
DRUG COMBINATIONS;
ELECTROLYTES;
FEMALE;
FUROSEMIDE;
GLOMERULAR FILTRATION RATE;
HEART FAILURE, CONGESTIVE;
HEART RATE;
HUMANS;
MALE;
MIDDLE AGED;
RECEPTORS, PURINERGIC P1;
SODIUM;
URINALYSIS;
XANTHINES;
|
EID: 0037133628
PISSN: 00097322
EISSN: None
Source Type: Journal
DOI: 10.1161/hc1102.105264 Document Type: Article |
Times cited : (337)
|
References (18)
|